- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Signe Harder
Total 1951 results
-
Dana-Farber Cancer InstituteCompleted
-
Dana-Farber Cancer InstituteWithdrawnBreast Cancer
-
Cindy HallerTerminatedCholestasis | Total Parenteral Nutrition-induced CholestasisUnited States
-
Dana-Farber Cancer InstituteTerminated
-
Dana-Farber Cancer InstituteCompletedStage I Breast Carcinoma | Stage II Breast CarcinomaUnited States
-
Dana-Farber Cancer InstituteCompletedBreast CancerUnited States
-
University Hospital Hradec KraloveUnknownAge Related Macular DegenerationCzech Republic
-
Dana-Farber Cancer InstituteCompletedAdvanced Solid Tumor | Metastatic Solid TumorUnited States
-
Dana-Farber Cancer InstituteCompletedGraft vs Host Disease | Chronic Graft vs Host Disease | cGVHDUnited States
-
Dana-Farber Cancer InstituteCompleted
-
Dana-Farber Cancer InstituteWithdrawnPancreatic Cancer, MetastaticUnited States
-
Dana-Farber Cancer InstituteWithdrawnOvarian Cancer | Fallopian Tube Cancer | Peritoneal CancerUnited States
-
Dana-Farber Cancer InstituteCompleted
-
Dana-Farber Cancer InstituteNot yet recruitingCancer Predisposition Syndrome | Predisposition, GeneticUnited States
-
Dana-Farber Cancer InstituteNot yet recruitingBreast Cancer | Breast Carcinoma | Breast Cancer FemaleUnited States
-
University Hospital Hradec KraloveRecruitingOrgan Transplant Failure or Rejection | Brain Damage Due to Hypoxia | Organ DonorsCzechia
-
Dana-Farber Cancer InstituteRecruitingPancreatic CancerUnited States
-
Dana-Farber Cancer InstituteRecruitingGraft Vs Host Disease | Acute-graft-versus-host Disease | Chronic Graft-versus-host-diseaseUnited States
-
Dana-Farber Cancer InstituteRecruitingOvarian Cancer | Endometrial Cancer | Ovarian Carcinoma | Ovarian Cancer Stage IV | Ovarian Cancer Stage III | Ovarian Cancer Stage 3 | Endometrial Cancer StageUnited States
-
University Hospital Hradec KraloveRecruitingEmbolism | Patent Foramen OvaleCzechia
-
Dana-Farber Cancer InstituteRecruitingCutaneous T Cell Lymphoma | Peripheral T Cell LymphomaUnited States
-
Dana-Farber Cancer InstituteRecruiting
-
Dana-Farber Cancer InstituteRecruitingBone Mineral Density | Childhood Cancer SurvivorsUnited States
-
Dana-Farber Cancer InstituteActive, not recruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Myelofibrosis | Chronic Myelomonocytic Leukemia | Myeloproliferative NeoplasmsUnited States
-
Dana-Farber Cancer InstituteActive, not recruiting
-
Dana-Farber Cancer InstituteActive, not recruitingRecurrent, Refractory, or High Risk Leukemias | Matched Targeted TherapyUnited States
-
Dana-Farber Cancer InstituteCompletedSolid Tumors | KRAS Mutant Non-Small Cell Lung CancerUnited States
-
Dana-Farber Cancer InstituteCompletedBreast CancerUnited States
-
Dana-Farber Cancer InstituteCompletedCarcinoid Tumor | Pancreatic Neuroendocrine TumorUnited States
-
Dana-Farber Cancer InstituteActive, not recruitingPediatric Cancer | Skin Inflammation | CNS Tumor, ChildhoodUnited States
-
Dana-Farber Cancer InstituteActive, not recruitingBreast CancerUnited States
-
Dana-Farber Cancer InstituteActive, not recruitingMultiple Myeloma | Lymphoblastic Lymphoma | Waldenstrom's Macroglobulinemia | Smoldering Multiple MyelomaUnited States
-
Dana-Farber Cancer InstituteCompletedBreast CancerUnited States
-
Dana-Farber Cancer InstituteTerminated
-
Dana-Farber Cancer InstituteActive, not recruitingBreast Cancer | Metastatic Breast CancerUnited States
-
Dana-Farber Cancer InstituteCompletedHematopoietic Stem Cell Transplantation (HSCT) | Acute GVH DiseaseUnited States
-
Dana-Farber Cancer InstituteWithdrawnBreast Cancer | Breast Neoplasms | Breast Carcinoma | Triple Negative Breast Cancer | Breast Cancer Stage II | Breast Cancer Stage III | Early Stage Triple-Negative Breast CarcinomaUnited States
-
Dana-Farber Cancer InstituteCompletedBreast Cancer | Lung Cancer | Gastrointestinal CancerUnited States
-
Dana-Farber Cancer InstituteCompleted
-
Dana-Farber Cancer InstituteCompletedCervical Cancer | Vaginal Cancer | Uterine Cancer | Carcinoma of the VulvaUnited States
-
Dana-Farber Cancer InstituteCompletedEarly Stage Breast Cancer | Breast Cancer Stage I | Breast Cancer Stage IIUnited States
-
Dana-Farber Cancer InstituteCompletedBreast Cancer | Prostate Cancer | Patient Engagement | Patient Satisfaction | Patient PreferenceUnited States
-
Dana-Farber Cancer InstituteCompletedStress | Anxiety | OncologyUnited States
-
Dana-Farber Cancer InstituteCompletedOther CancerUnited States
-
University Hospital Hradec KraloveCompletedCovid19 | DNA Damage | Organ Failure, MultipleCzechia
-
Dana-Farber Cancer InstituteCompleted
-
Dana-Farber Cancer InstituteCompleted
-
Harley Street (CPC) LimitedEnrolling by invitationChronic PainUnited Kingdom
-
Dana-Farber Cancer InstituteCompleted
-
Dana-Farber Cancer InstituteCompletedProstate CancerUnited States